Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Kidney and Blood Pressure Research • 2003 | View Paper
“These results suggest that forearm bone loss after intravenous pamidronate treatment for moderate-to-severe Paget's disease can largely be prevented by administration of calcium and calcitriol.”
“ Oral pamidronate caused a dose-related reduction on the biochemical markers of bone resorption, i.e. fasting urinary calcium , hydroxyproline, pyridinoline and deoxypyridinoline that was seen already after the first week.”
Upsala journal of medical sciences • 1991 | View Paper
“All patients responded to APD with a rapid decrease of plasma calcium concentration from 3.44 +/- 0.10 mmol/l at day 0 to 2.33 +/- 0.06 at day 6, p less than 0.001).”
Schweizerische medizinische Wochenschrift • 1988 | View Paper
“… (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (… calcium (1 g/day) with that of calcium alone on the bone mass of patients receiving long-term glucocorticoid therapy, the mean ….2% between 0 and 6 months (p less than 0.06) and then remained stable between 6 and 12 months.”
“In terms of percentage BMD change at the femoral neck, both pamidronate and ibandronate combined with calcium demonstrated a remarkable gain compared with calcium (MD, 7.02; 95% CrI, 0.30–13.29 and MD, 7.30; 95% CrI, 0.32–14.22, respectively).”